Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 6 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Teva Pharmaceutical Industries Ltd (ADR) have a median target of 23.00, with a high estimate of 26.00 and a low estimate of 9.00. The median estimate represents a 34.66% increase from the last price of 17.08.
High | 52.2% | 26.00 |
Med | 34.7% | 23.00 |
Low | -47.3% | 9.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Jan 29, 2025.
Average growth rate | +13.72% |
Average growth rate | +1.68% |
More ▼
Revenue history & estimates in USD
Average growth rate | +3.63% |
Average growth rate | -1.47% |
More ▼